If BPC-157 is reducing inflammation at the tissue level, hs-CRP should trend downward
Remember, controlling diabetes takes time and hard work, just like a marathon
Current evidence suggests that BPC-157 is not a weight loss peptide and does not directly burn fat, suppress appetite, or significantly increase metabolism
Figure 2: The pineal glands anatomical position within the neuroendocrine hub explains its outsized influence on circadian, immune, and hormonal systems, making Epitalons tissue-specific action particularly significant
Predictors of 15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1-4
A Hims & Hers spokesperson told Reuters the company does not expect any impact on its business from the FDAs proposal, saying, There are no GLP1s compounded by 503B facilities accessible through our platform, and 503B facilities should not currently be compounding GLP1s because they are not in shortage. Most telehealth companies use 503A pharmacies to fill their personalized compounded doses, said Rosalie Hoyle, a research scientist at health consultancy Avalere, adding the exclusion from the 503B bulks list may not operationally impact current compounding of GLP-1 drugs
